Overview

Testosterone Replacement for Male Opioid Agonist Maintained Patients

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yale University
Treatments:
Analgesics, Opioid
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate